En españolGoal assessment of use reduction for illicit substances offers a increased trouble given variability and uncertainty from the composition and purity of illicit drugs bought. This problem could account for part of the reluctance on the pharmaceutical business to take a position in acquiring new remedies directed at cutting down drug use